Neurochemical changes in the developing rat hippocampus during prolonged hypoglycemia by Rao, R. et al.
, ,1
*Division of Neonatology, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA
Center for Neurobehavioral Development, University of Minnesota, Minneapolis, Minnesota, USA
Department of Educational Psychology, College of Education and Human Development, University of Minnesota, Minneapolis,
Minnesota, USA
§Center for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA
Hypoglycemia is a common metabolic condition in human
infants. In spite of the potential for neuronal injury, the
effects of hypoglycemia on the developing brain are
incompletely understood (Cornblath et al. 2000). Even
though glucose is its principal energy substrate, a lower
energy requirement, secondary to decreased neuronal
activity, combined with higher brain glycogen stores and
ability to utilize alternate energy substrates is proposed to
protect the developing brain during hypoglycemia (Nehlig
and Pereira de Vasconcelos 1993; Vannucci and Vannucci
2001). Conversely, a proportionately higher demand for
glucose, secondary to an increased brain-to-bodyweight
ratio, combined with poor high-energy phosphate reserves
and an unpredictable supply of alternate substrates,
because of immaturity of the counter-regulatory system,
may pre-dispose the developing brain to injury during
hypoglycemia (McGowan and Perlman 2006; Burns et al.
2008).
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Abstract
Hypoglycemia is common during development and is asso-
ciated with the risk of neurodevelopmental deficits in human
infants. The effects of hypoglycemia on the developing hip-
pocampus are poorly understood. The sequential changes in
energy substrates, amino acids and phosphocreatine were
measured from the hippocampus during 180 min of insulin-
induced hypoglycemia (blood glucose < 2.5 mmol/L) in
14-day-old rats using in vivo 1H NMR spectroscopy.
Hypoglycemia resulted in neuroglycopenia (brain glucose
< 0.5 lmol/g). However, the phosphocreatine/creatine (PCr/
Cr) ratio was maintained in the physiological range until
approximately 150 min of hypoglycemia, indicating that
energy supply was sufficient to meet the energy demands.
Lactate concentration decreased soon after the onset of
neuroglycopenia. Beyond 60 min, glutamine and glutamate
became the major energy substrates. A precipitous decrease
in the PCr/Cr ratio, indicative of impending energy failure
occurred only after significant depletion of these amino acids.
Once glutamate and glutamine were significantly exhausted,
aspartate became the final energy source. N-acetylaspartate
concentration remained unaltered, suggesting preservation
of neuronal/mitochondrial integrity during hypoglycemia.
Correction of hypoglycemia normalized the PCr/Cr ratio and
partially restored the amino acids to pre-hypoglycemia levels.
Compensatory neurochemical changes maintain energy
homeostasis during prolonged hypoglycemia in the devel-
oping hippocampus.
Keywords: 1H NMR spectroscopy, hippocampus, hypogly-
cemia, neurochemistry, newborn, rat.
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When glucose supply is compromised, compensatory
changes that maintain cerebral oxidative metabolism are
initiated in the developed brain. The amino acids, glutamate
and glutamine become the major sources of carbon for
supporting cerebral tricarboxylic acid (TCA) cycle activity
(Lewis et al. 1974a; Behar et al. 1985; Sutherland et al.
2008). Combined with an enhanced substrate delivery
through increased cerebral blood ﬂow (CBF) and mobiliza-
tion of brain glycogen stores, these endogenous substrates
maintain energy homeostasis and prevent neuronal injury
(Choi et al. 2001, 2003; Sutherland et al. 2008).
The neurochemical changes in the developing brain during
hypoglycemia are not well understood. Speciﬁcally, the role
of cerebral amino acids in preserving energy sufﬁciency has
yet to be determined. The objective of the present study was
to evaluate the sequential changes in the neurochemical
proﬁle of the hippocampus during prolonged hypoglycemia
using high-ﬁeld in vivo 1H NMR spectroscopy in developing
rats. Previous studies have demonstrated the suitability of
this method for the simultaneous and longitudinal quantiﬁ-
cation of neurochemical markers of energy metabolism,
neuronal and glial integrity, amino acids and neurotransmit-
ters in the brain regions of developing rats (Tkac et al. 2003;
Rao et al. 2007). In the present study, we focused on the
hippocampus because of its vulnerability during hypoglyce-
mia in human infants and developing rodents (Anderson




Experiments were performed using postnatal day (P) 14 Sprague–
Dawley rat pups (average body weight, 33 g). Hippocampal
development in P14 rats is comparable to that in full term newborn
human infants (Avishai-Eliner et al. 2002). Pregnant dams were
purchased (Harlan Sprague Dawley, Indianapolis, IN, USA) and
allowed to deliver spontaneously. The litter size was culled to eight
on P3. Rats were maintained on 12 h day-and-night cycle (lights out
at 18:00 h) in a temperature and humidity controlled room. Pups
were allowed to nurse ad libitum until the day of the experiment.
Pain and distress were minimized using anesthesia during the
procedures. The Institutional Animal Care and Use Committee
approved all procedures.
Rat pups (n = 6, hypoglycemia; n = 2, control) underwent
tracheotomy for respiratory assistance using a small animal
ventilator (Kent Scientiﬁc, Litchﬁeld, CT, USA). An indwelling
intraperitoneal catheter (24G Jelco; Smiths Medical, Carlsbad, CA,
USA) was placed for administering drugs and secured in place using
glue (Loctite Easy-Squeeze Super Glue Gel; Henkel Corporation,
Rocky Hill, CT, USA). The ventilator settings were adjusted based
on end tidal CO2 monitored continuously using a capnometer
(Model SC-300; BCI International, Waukesha, WI, USA) (Choi
et al. 2001). The rectal temperature was maintained at 36.4 ± 1.0C
using thermostat-regulated warm water circulating in tubes (Cole
Palmer, Vernon Hills, IL, USA). Heart rate and respiratory rate were
continuously monitored using a MR-compatible monitoring system
(Model 1025; SA Instruments, Inc., Stony Brook, NY, USA).
Induction of hypoglycemia
Acute hypoglycemia was induced as previously described (Ennis
et al. 2008). Brieﬂy, pups were fasted for 4 h by separating from the
dam. Human regular insulin (Novo Nordisk Inc., Clayton, NC, USA)
was injected in a single dose of 6 IU/kg i.p. The target plasma
glucose concentration was < 2.5 mmol/L, a value conventionally
used to deﬁne hypoglycemia in human newborn infants (Cornblath
et al. 2000; Burns et al. 2008). Equivalent volume of normal saline
was injected to rats in the control group. Plasma glucose concen-
tration was determined in blood samples from the tail before and at
the conclusion of NMR spectroscopy in a glucose analyzer (Model
GM7 Micro-stat; Analox Instruments, London, UK). The small
blood volume of P14 rats and technical difﬁculties with blood
collection inside the magnet precluded frequent plasma glucose
measurements in these rats. Therefore, to conﬁrm hypoglycemia
during 1H NMR spectroscopy, littermates were subjected to
hypoglycemia using the same insulin dose and monitored outside
the magnet (n = 6). Plasma glucose was determined every 30 min,
and b-hydroxybutyrate concentration was determined at 0 min,
120 min and 240 min (Precision Xtra; Abbott Laboratories, Oxon,
UK) after insulin administration in these rats. Hypoglycemia was
terminated 240 min after insulin administration by injecting 0.2 mL
of 10% dextrose, a dose that normalizes brain glucose concentration
in hypoglycemic newborn rats (Vannucci and Vannucci 1978).
In vivo 1H NMR spectroscopy
1H NMR spectroscopy was performed using a horizontal bore 9.4T/
31 cm magnet (Varian/Magnex; Oxford, UK) equipped with a
15-cm internal diameter gradient coil insert (450 mT/m, 200 ls) and
strong second-order shims (XZ = YZ = Z2 = 2000 Hz/cm2, XY =
X2Y2 = 1000 Hz/cm2). The magnet was interfaced to a Varian
INOVA console (Varian, Inc.; Palo Alto, CA, USA).
In vivo 1H NMR spectra were collected using previously described
protocol (Tkac et al. 2003). Brieﬂy, all ﬁrst- and second-order
shims were adjusted using FASTMAP method (Gruetter and Tkac
2000). Ultra-short echo-time STEAM (echo time TE = 2 ms,
repetition time TR = 5 s) combined with outer volume suppression
and VAPOR water suppression (Tkac et al. 1999) was used to
acquire spectral data from 8 lL (2.5 · 1.3 · 2.5 mm3) volume
of interest (VOI) centered in the left dorsal hippocampus
(Tkac et al. 2003; Rao et al. 2007). Multi-slice coronal and
sagittal RARE imaging technique (echo train length ETL = 8,
echo spacing ESP = 15 ms, TE = 60 ms, matrix = 256 · 128,
FOV = 25 mm · 25 mm, slice thickness = 1 mm) was used for
selecting the VOI. 1H NMR spectra were acquired sequentially
during the entire period of hypoglycemia. Acquiring 160 transients
per spectrum with 5 s repetition time resulted in 13.5 min
time resolution. The effect of 10% dextrose administration on
the neurochemistry was also assessed in two rats subjected to
hypoglycemia.
Quantification of metabolites
Metabolite concentrations were quantiﬁed using LCModel with
macromolecule spectra included in the basis set (Provencher 1993;
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Tkac et al. 2003). Unsuppressed water signal was used as internal
reference. A brain water content of 83% was used in the calculation,
based on our previous study (Tkac et al. 2003). The concentrations
of the following 17 metabolites were determined: alanine, ascorbate,
aspartate (Asp), b-hydroxybutyrate, creatine (Cr), GABA, glucose,
glutamate (Glu), glutamine (Gln), GSH, lactate (Lac), myo-inositol,
N-acetylaspartate (NAA), N-acetylaspartylglutamate, phosphocrea-
tine (PCr), phosphoethanolamine and taurine. The sum of glycer-
ophosphocholine (GPC) and phosphocholine (PC) was determined,
because of the inability to reliably differentiate the individual
compounds because of their spectral similarity. The Glu/Gln and
PCr/Cr ratios were calculated. Thus, the neurochemical proﬁle
consisted of 18 metabolites and two ratios.
Statistical Analysis
The changes in plasma glucose and blood b hydroxybutyrate were
assessed using ANOVA. The effect of hypoglycemia on individual
metabolites was determined using ANOVA and linear regression
analysis as indicated. Within group differences were established
using Bonferroni-adjusted independent t tests. The SPSS program
(version-15; SPSS, Chicago, IL, USA) was used. Data are presented
as mean ± SD. The statistical signiﬁcance criterion was set at
a = 0.05.
Results
Plasma glucose and blood b-hydroxybutyrate
concentrations
The plasma glucose concentrations were similar in the rats
studied in the magnet and the littermates used for bench-top
experiments. The target plasma glucose concentration
(< 2.5 mmol/L) was achieved 60 min after insulin adminis-
tration and was maintained until dextrose administration at
240 min (Fig. 1). The lowest glucose concentration
(0.81 ± 0.03 mmol/L) was observed at 120 min (Fig. 1).
The b-hydroxybutyrate concentration in blood decreased
from 1.43 ± 0.01 mmol/L prior to insulin injection (i.e. at
time zero) to 0.60 ± 0.02 mmol/L and 0.68 ± 0.03 mmol/L
at 120 min and 240 min, respectively (p < 0.001, each). The
b hydroxybutyrate concentration was 2.3 ± 0.2 mmol/L at
the conclusion of 1H NMR spectroscopy in the two rats in the
control group.
Neurochemical analysis
Sequential in vivo 1H NMR spectra (12–16 spectra per rat)
were obtained, beginning at 44 ± 11 min after insulin
administration and continuing until 270 ± 23 min (range:
247–306 min). Data from one rat in the hypoglycemia group
was excluded because of the presence of irregular heart rate,
persistent hypothermia and elevated lactate, suggesting
unstable physiology during the study. Thus, the ﬁnal analysis
included data from 5 hypoglycemic and 2 control rats.
The heart rate (beats per min) increased from 375 ± 15 to
410 ± 14 within 60 min of insulin administration and was
maintained at 445 ± 19 thereafter. The heart rate rapidly
decreased to 395 ± 19 following 10% dextrose administra-
tion. The heart rate did not alter during the entire experi-
mental period in the two control rats.
A representative in vivo 1H NMR spectrum obtained
during hypoglycemia and the typical location of the VOI in
hippocampus is shown in Fig. 2. The water signal linewidth
decreased from approximately 9 Hz to 7 Hz within 120 min
after insulin administration in all rats. The concentrations of
alanine, b-hydroxybutyrate and glucose decreased below
detection threshold (0.5 lmol/g) within 120 min after insulin
administration (i.e. during the initial 60 min of hypoglyce-
mia, arbitrarily labeled Phase I). Lac concentration decreased
50% during this period.
The sequential changes in Cr, PCr, aspartate, glutamate,
glutamine and lactate concentrations over time in a rat are
shown in Fig. 3. During the initial 60 min of hypoglycemia
(i.e. Phase I), other than a slight decrease in PCr and a
corresponding increase in Cr concentration, the neurochem-
ical proﬁle was unaltered. Between 120 and 160 min after
insulin administration (i.e. 60–100 min of hypoglycemia,
Phase II), ﬁrst glutamine and then glutamate concentrations
decreased steadily with a corresponding increase in aspartate
concentration. The PCr/Cr ratio was maintained between 1.1
and 1.2 during this period. During the subsequent, very brief
period (160–180 min after insulin administration, Phase III),
a precipitous decrease in PCr with an equally rapid reciprocal
increase in Cr was observed that resulted in very low PCr/Cr
ratio (£ 0.14). The concentration of glutamine decreased
below the detection threshold (0.5 lmol/g), glutamate
decreased by 75%, and aspartate increased approximately
300% of the corresponding pre-hypoglycemia levels, respec-
tively, during this phase (100–120 min of hypoglycemia).
These dramatic changes were clearly visible in the 1H NMR
spectra acquired during this period (Fig. 4). During the
subsequent period (180–240 min after insulin administration,
Fig. 1 Plasma glucose concentration after insulin administration in
postnatal day 14 rats. Values are mean ± SEM, n = 6–8 at each time.
The dashed line represents 2.5 mmol/L, a value conventionally used
to define hypoglycemia in newborn infants.
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i.e. 120–180 min of hypoglycemia, Phase IV), PCr/Cr ratio
remained close to zero with further decrease in glutamate
concentration to approximately 10% of pre-hypoglycemia
level. Asp concentration also began to decrease during this
period.
The patterns of neurochemical changes were similar in all
ﬁve hypoglycemic rats (Fig. 5). However, there were inter-
animal variations in the time-course of PCr and amino acid
changes (Fig. 5a). Nevertheless, when the trajectories of the
neurochemical changes were shifted along the time axis, such
that the precipitous phase of PCr decrease in individual rats
were aligned with each other, a robust consistency in the
pattern of amino acid changes was observed (Fig. 5b). There
was a strong correlation between PCr/Cr ratio and gluta-
Fig. 2 In vivo 1H NMR spectrum measured
from the hippocampus of a postnatal day 14
rat. The inset shows the MRI with the vol-
ume of interest (VOI) from which the spec-
tra were collected. STEAM, TE = 2 ms,
TR = 5 s, number of transients NT = 160.
See Materials and Methods for abbrevia-
tions.
Fig. 3 Changes in the concentrations of
creatine (Cr), phosphocreatine (PCr), glu-
tamate (Glu), glutamine (Gln), aspartate
(Asp) and lactate (Lac) in the hippocampus
during hypoglycemia and following 10%
dextrose administration in a postnatal day
14 rat. The arrow indicates the time of 10%
dextrose administration.
Fig. 4 In vivo 1H NMR spectra from the
hippocampus during early (120–165 min,
bottom) and late (195–240 min, middle)
phases of hypoglycemia in a postnatal day
14 rat (same as the one shown in Fig. 3).
The differences between the two spectra
are shown in the top. STEAM, TE = 2 ms,
TR = 5 s, number of transients NT = 480.
 2010 The Authors
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mate + glutamine concentration (R2 = 0.86; p < 0.001, Fig-
ure S1). The rate of glutamate + glutamine decrease was
always greater than the corresponding increase in aspartate
concentration (Fig. 6). Overall, substantial net consumption
of amino acids (glutamate + glutamine + asparatate) oc-
curred during hypoglycemia.
In addition to the changes in amino acids, a modest, an
approximately linear change in the concentrations of the
following neurochemicals were observed during hypoglyce-
mia: ascorbate (rate of decrease, 0.17 lmol/g/h), GABA
(0.10 lmol/g/h), N-acetylaspartylglutamate (0.14 lmol/g/h),
taurine (0.36 lmol/g/h) and Cr+PCr (0.26 lmol/g/h)
concentrations decreased (p < 0.01, each; Table S1). The
concentration of GPC + PC increased (0.05 lmol/g/h,
p = 0.015; Table S1). Myo-inositol, GSH, phosphoethanol-
amine and NAA concentrations were not altered during
hypoglycemia.
Following 10% dextrose administration, the brain
glucose concentration increased to 1.63 ± 0.20 and 2.52 ±
0.37 lmol/g in the two hypoglycemic rats. Lac concentration
increased above the pre-hypoglycemia level (2.99 ±
0.69 lmol/g vs. 1.73 ± 0.78 lmol/g). PCr/Cr ratio was fully
(a) (b)
Fig. 5 (a) The time course of changes in phosphocreatine (PCr),
glutamine (Gln), glutamate (Glu), aspartate (Asp) concentrations in
the hippocampus of individual postnatal day 14 rats during hypo-
glycemia. (b) The trajectories of the neurochemical changes are
shifted along the time axis, such that the precipitous phase of PCr
decrease in individual rats is aligned with each other, demonstrating
robust consistency in the pattern of amino acid changes among the
rats (n = 5).
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restored and glutamate concentration was restored to 88% of
the corresponding pre-hypoglycemia levels, respectively.
However, there was no recovery of glutamine during the
50 min of observation. The substantially decreased total
amino acid concentration was only partially restored
[(Glu + Gln + Asp): 5.8 ± 0.5 lmol/g vs. 10.5 ± 0.2 lmol/
g during the initial 120 min after insulin administration,
p < 0.001] following dextrose administration.
In the two control rats, sequential spectra were obtained
for 115 min (nine individual blocks) and 269 min (16
individual blocks), starting at 24 min and 39 min after
normal saline injection, respectively. Brain glucose concen-
tration was maintained at 2.88 ± 0.18 lmol/g during the
entire period of 1H NMR spectroscopy. None of the 18
simultaneously measured metabolites was altered in these
rats (data not shown).
Discussion
This study presents the sequence of neurochemical changes
resulting from insufﬁcient glucose supply to the develop-
ing rat hippocampus. Simultaneous detection of changes in
18 metabolites, enabled by in vivo 1H NMR spectroscopy
at 9.4T, revealed sequential phases of hypoglycemia
characterized by utilization of various substrates as
endogenous fuel supplies. The results demonstrate that
the duration of hypoglycemia is a critical factor that
determines the neurological sequelae, because the ability to
maintain energy homeostasis is dependent on the avail-
ability of alternate substrates, whose supplies are limited.
Nevertheless, these compensatory changes preserved
energy sufﬁciency for extended periods of time and may
explain the relative resistance of the developing hippo-
campus to injury in this model (Ennis et al. 2008; Rao
et al. 2009).
During cerebral glycopenia, CBF is increased to enhance
substrate delivery (Mujsce et al. 1989; Choi et al. 2001).
Brain glycogen is mobilized to supply glucose for energy
production (Vannucci and Vannucci 1978; Choi et al. 2003).
When these measures become inadequate, available endog-
enous substrates replenish TCA cycle intermediates through
anaplerotic reactions (Fig. 7). This simpliﬁed schema also
includes information on the generation of ATP, NADH or
FADH2 and highlights the reaction steps of the intermediary
metabolism contributing to the energy production during
neuroglycopenia.
The glucose concentration in the hippocampus was
< 0.5 lmol/g within 60 min of the onset of hypoglycemia.
Nonetheless, the PCr/Cr ratio was maintained in the phys-
iological range, indicating that energy production was
sufﬁcient to meet the energy demands. Decreased glucose
demand, resulting from suppressed neuronal activity in the
anesthetized immature brain may be partly responsible for
the energy balance. Additionally, other neuroprotective
changes were initiated. A compensatory increase in CBF
could be deduced in the present study from the narrowing of
the spectral linewidth soon after the onset of neuroglycope-
nia. An increased oxyhemoglobin/deoxyhemoglobin ratio,
secondary to enhanced oxygen delivery is likely responsible
for this ﬁnding (Choi et al. 2001). The increased heart rate,
mediated by catecholamines also potentially augmented
CBF. Ketone bodies, such as b-hydroxybutyrate and lactate
could be responsible for energy production during the phase I
of hypoglycemia (Hernandez et al. 1980; Nehlig and Pereira
de Vasconcelos 1993). The role of b-hydroxybutyrate was
likely limited in the present study, as ketogenesis was
suppressed following insulin administration. On the other
hand, the decreased lactate concentration suggests that it
likely contributed to energy production. Lac uptake and
utilization increases during hypoglycemia in the developing
brain (Hernandez et al. 1980; Thurston et al. 1983). The
shift of the redox state during hypoglycemia is conducive for
the efﬁcient oxidation of lactate (Lewis et al. 1974a; Norberg
and Siesio 1976). Although changes in brain glycogen were
not measured in the present study, a previous study
demonstrated that glycogenolysis commences during this
period of hypoglycemia in newborn rats (Vannucci and
Vannucci 1978).
When these initial compensatory mechanisms were unable
to maintain energy homeostasis, cerebral amino acids
probably became important energy fuels (Fig. 7), similar to
the mature brain (Behar et al. 1985; Sutherland et al. 2008).
The pyruvate carboxylase reaction, the most important
anaplerotic pathway to replenish the TCA cycle intermedi-
ates, is unlikely to be functional during prolonged hypogly-
cemia, secondary to insufﬁcient production of pyruvate.
Therefore, as in the mature brain, the ‘emergency’ anaple-
Fig. 6 Rate of change in the concentration of glutamine (Gln), gluta-
mate (Glu) and aspartate (Asp) in the hippocampus during different
phases of hypoglycemia and following 10% dextrose administration in
postnatal day 14 rats (n = 5).
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rotic reactions involving glutamate and glutamine, likely
became the primary sources of the carbon skeleton for the
TCA cycle during the phase II of hypoglycemia (Tews et al.
1965; Norberg and Siesio 1976; Behar et al. 1985; Erecinska
et al. 1988; Yudkoff et al. 1994; Waagepetersen et al. 2005;
McKenna 2007; Olstad et al. 2007a; Sutherland et al. 2008).
In neurons, glutamine is readily deaminated by the action
of phosphate-activated glutaminase to glutamate, which then
enters the TCA cycle. Glutamate can generate a-ketogluta-
rate via two pathways: via aspartate aminotransferase (AAT)
reaction and glutamate dehydrogenase (GDH) reaction
(Fig. 7) (see McKenna 2007 and the references therein).
There is 3–5 fold increase in phosphate-activated glutamin-
ase, AAT and GDH activities in the rat hippocampus between
birth and P14 (Rothe et al. 1983; Schunzel et al. 1986; Wolf
et al. 1988), attesting to its ability to efﬁciently use
glutamine and glutamate for energy production.
Our data indicate that a substantial ﬂux of glutamate to
a-ketoglutarate was through the GDH pathway (Fig. 7, black
arrows), as the increase in aspartate concentration was not
proportional to the decrease of glutamate + glutamine. This
is dissimilar to the data from adult rats, where a ‡ 1 : 1
Fig. 7 Simplified schema of metabolic pathways during acute hypo-
glycemia in the developing hippocampus. Substrates that support
energy metabolism via the tricarboxylic acid (TCA) cycle during neu-
roglycopenia are highlighted. The figure also includes information on
the generation of ATP, NADH or FADH2. Once glycogen, lactate and
b-hydroxybutyrate are significantly depleted, glutamine and glutamate
become the major sources of carbon for supporting TCA cycle. In
neurons, glutamine is readily converted by the phosphate-activated
glutaminase (PAG) to glutamate, which then enters the TCA cycle.
Glutamate generates a-ketoglutarate from two pathways: via aspar-
tate aminotransferase (AAT) pathway (blue) or glutamate dehydro-
genase (GDH) pathway (black). The former pathway produces
aspartate in a stoichiometric amount. The latter pathway allows
complete oxidation of glutamate. However, this reaction requires a
continuous supply of pyruvate. The conversion of malate into pyruvate
through the malic enzyme (ME) is probably the primary pyruvate
recycling pathway. Pyruvate recycling from oxaloacetate via phos-
phoenolpyruvate carboxykinase (PEPCK) reaction is less likely under
the compromised energy status during hypoglycemia. Even though
GABA can support energy production by producing succinate via
GABA transaminase (GABA-T) and succinate-semialdehyde dehy-
drogenase (SSDH) reactions, the contribution is likely to be minor.
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relationship between aspartate production and glutamate
consumption is seen (Lewis et al. 1974b; Yudkoff et al.
1994; McKenna 2007; Sutherland et al. 2008), suggesting
that the AAT pathway pre-dominates in the mature brain
(Fig. 7, blue arrows). While this ‘truncated’ TCA cycle
involving the AAT pathway yields the urgently needed
energy, the ﬁve-carbon skeleton of glutamate is only partially
oxidized, producing the four-carbon skeleton amino acid,
aspartate. Conversely, the GDH pathway permits complete
oxidation of glutamate. However, oxidation of a-ketogluta-
rate in the TCA cycle cannot continue without a constant
supply of the acetyl-CoA. Hence, full oxidation of glutamate,
entering the TCA cycle via the GDH pathway, would be
possible if pyruvate recycling is active (Olstad et al. 2007b).
Cell culture studies have demonstrated that pyruvate recy-
cling is suppressed during severe hypoglycemia, possibly
because of lack of high-energy phosphates and reducing
equivalents (Bakken et al. 1998a,b). Therefore, pyruvate
recycling from oxaloacetate via the combined actions of
phosphoenolpyruvate carboxykinase and pyruvate kinase
may be suppressed in the present study, as the ﬁrst step in the
reaction requires energy. However, the conversion of malate
into pyruvate through the malic enzyme reaction is possible,
as this reaction does not require any energy. The generated
pyruvate reenters the TCA cycle and enables total oxidation
of ﬁve-carbon skeleton through the complete TCA cycle
(Fig. 7).
A precipitous decrease in PCr/Cr ratio was observed
during the phase III of hypoglycemia. This implies compro-
mised energy metabolism, as PCr concentration below
0.5 lmol/g is associated with decreased ATP production
(Vannucci and Vannucci 1978; Behar et al. 1985). The rapid
rate of decrease of glutamate and glutamine during this phase
suggest that signiﬁcant alterations in these amino acids are
the harbingers of impending energy failure during hypogly-
cemia. This extreme metabolic deviation from homeostasis
was clearly discernible in the 1H NMR spectra obtained
during this phase (Fig. 4). Observed metabolite changes
indicated that glutamate remained the only source feeding the
TCA cycle during this phase of hypoglycemia (Fig. 7).
During the phase IVof hypoglycemia, when the glutamate
and glutamine pools were nearly exhausted, accumulated
aspartate became the ﬁnal source of carbon for energy
production (Fig. 7). Complete oxidation of aspartate in the
TCA cycle is possible only if there is active pyruvate
recycling (Olstad et al. 2007b). Depletion of all amino acids
is most likely the terminal stage of hypoglycemia, when the
rate of ATP production is no longer able to support the
minimal energy demands of the brain and leads to neuronal
injury (Sutherland et al. 2008).
Additional neuroprotective mechanisms were likely oper-
ative during hypoglycemia in the present study. The
decreased GABA concentration may suggest its participation
in energy production through GABA succinic acid pathway
(Lewis et al. 1974b; Tillakaratne et al. 1995) (Fig. 7).
However, the contribution is likely to be minor, as
a-ketoglutarate produced from glutamate increases, oxidative
metabolism supported by GABA decreases (Davis et al.
1970). Furthermore, decreased GABA concentration may be
a reﬂection of decreased availability of its precursor,
glutamate, during hypoglycemia (Madl and Royer 2000).
To our knowledge, alterations in ascorbate concentration
during hypoglycemia have not been previously described.
Due its role as an antioxidant and free radical scavenger
(Rice et al. 2002), decreased ascorbate may reﬂect the
presence of oxidative stress during hypoglycemia (McGowan
et al. 2006; Suh et al. 2008). An approximately 10%
decrease in taurine concentration was observed during
hypoglycemia. Taurine is released into the extracellular
space, presumably as an osmoregulatory response to brain
edema and osmotic changes during hypoglycemia (Sandberg
et al. 1986; Silverstein et al. 1990; Gisselsson et al. 1998;
Pasantes-Morales et al. 2002). The extracellular release of
taurine is considered a feedback mechanism for preventing
excessive calcium inﬂux during glutamate- and aspartate-
mediated excitotoxicity during hypoglycemia (Sandberg
et al. 1986; Silverstein et al. 1990; Chen et al. 2001). The
observed small decrease in taurine concentration can be
explained by its rapid efﬂux from the interstitial space of the
brain to circulating blood by the efﬁcient taurine transport
system at the blood-brain barrier (Lee and Kang 2004). Of
note, the effect of hypoglycemia on taurine appears to be
age-related, being demonstrated in the developing brain and
not in the mature brain (Wong and Tyce 1983; Engelsen
et al. 1986; Petroff et al. 1988). The membrane phospholipid
precursors, GPC + PC increased, potentially reﬂecting mem-
brane breakdown or impaired repair during hypoglycemia
(Agardh and Siesjo 1981; Sutherland et al. 2008). However,
no changes in NAA were observed, suggesting the neuronal/
mitochondrial integrity was intact. This is consistent with the
previous studies in adult rats (Behar et al. 1985; Sutherland
et al. 2008) and corroborates the absence of neuronal injury
in the hippocampus during moderate hypoglycemia (Yamada
et al. 2004; Tkacs et al. 2005; Ennis et al. 2008; Rao et al.
2009; Haces et al. 2010).
Even though administration of 10% dextrose corrected
neuroglycopenia and normalized PCr, the neurochemical
proﬁle remained abnormal, similar to the mature brain (Tews
et al. 1965; Behar et al. 1985; Sutherland et al. 2008). An
accelerated rate of glycolysis or inability to oxidize pyruvate,
secondary to impaired pyruvate dehydrogenase activity
potentially explains the increased lactate during recovery
(Behar et al. 1985; Sutherland et al. 2008). A limited supply
of branched chain amino acids, such as leucine may be
responsible for the incomplete recovery of glutamate, and
suboptimal energy production post-hypoglycema may
explain the non-recovery of glutamine, as its synthesis by
glutamine synthetase requires ATP (Davis et al. 1970;
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Sutherland et al. 2008). The altered amino acids may also
imply an impaired glutamate-glutamine cycle post-hypogly-
cemia (Sutherland et al. 2008). On a functional level,
because of its central role in neurotransmission and syna-
ptogenesis, incomplete recovery of glutamate may adversely
impact hippocampal development and function (Yamada
et al. 2004).
As we did not monitor the electrical activity of the brain,
we are unable to correlate the neurochemical changes with
the functional effects of hypoglycemia. However, previous
studies in developing animals have demonstrated that
hypoglycemia of comparable severity is not associated with
EEG isoelectricity or convulsions (Petroff et al. 1988;
Yamada et al. 2004). This limitation of our study also
precludes direct comparison with previous studies in adult
rats, which typically have induced a more severe hypogly-
cemia (plasma glucose < 1.0 mmol/L) that is associated with
EEG isoelectricity (Lewis et al. 1974b; Agardh et al. 1978;
Butterworth et al. 1982; Behar et al. 1985; Sutherland et al.
2008). These studies have demonstrated that energy failure
and signiﬁcant depletion of amino acids, as observed during
the phase III in the present study, occurs only after the onset
of isoelectric EEG traces or convulsions. We are unaware of
previous in vivo studies that monitored the sequential
neurochemical changes in the hippocampus during hypogly-
cemia of comparable severity and duration in adult rats. A
previous in vivo 13C and 1H NMR spectroscopy study of
brain glycogen mobilization during moderate hypoglycemia
(plasma glucose < 2 mmol/L for 2 h) reported minor
changes in energy markers and amino acids in the VOI
encompassing the cerebral cortex, hippocampus and striatum
regions in adult rats (Choi et al. 2003). Collectively, these
results suggest that the neurochemical changes may differ in
the developing and mature brains during hypoglycemia.
Future studies of hypoglycemia of equivalent severity and
duration are necessary to conﬁrm this hypothesis and to
establish its role in the age- and region-speciﬁc vulnerability
to hypoglycemia-induced injury (Tkacs et al. 2005; Ennis
et al. 2008; Rao et al. 2009; Haces et al. 2010).
The results of the study may have clinical implications
for human infants at risk of hypoglycemia. Currently, the
management of hypoglycemia is based on plasma glucose
measurements (Cornblath et al. 2000). The study demon-
strates the poor relationship between plasma glucose and
cerebral energy metabolism during hypoglycemia. The
prediction of CNS injury based solely on plasma glucose
becomes problematic under these circumstances. The sensi-
tivity of the NMR method also attests to its potential for
monitoring the effects of hypoglycemia in human infants and
children.
In summary, acute hypoglycemia was associated with
compensatory neurochemical changes in the developing rat
hippocampus. These changes correlated with the duration of
hypoglycemia and may represent compensatory mechanisms
for preserving energy homeostasis and preventing neuronal
injury. While these alterations appear to be beneﬁcial in the
short-term, their long-term impact on hippocampal structure
and function has yet to be established. A thorough under-
standing of the effect of hypoglycemia on regional neuro-
chemistry would aid in the development of optimum
preventive and therapeutic strategies for at-risk human
infants and children.
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